RANI
Rani Therapeutics Holdings Inc
0.8288$
+7.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -453.7% | – | – | – | -841.9% | -4,737.8% | – | – | 20.1% | -380.4% | -528.5% | -416.1% | |
| – | 8.3% | – | – | – | 25.9% | 145.9% | – | – | 12.7% | 9.4% | 8.9% | 14.8% | |
| – | 163.1% | – | – | – | 388.2% | 2,282.0% | – | – | 153.2% | 122.0% | 141.9% | 186.4% | |
| – | -108.7% | – | – | – | -110.1% | 16.3% | – | – | 408.9% | -56.2% | -186.6% | 32.1% | |
| – | 6.1% | – | – | – | 3.0% | 29.7% | – | – | 0.0% | 0.9% | 1.9% | 1.0% | |
| – | 482.7% | – | – | – | 245.2% | 10,598.3% | – | – | -2,119.9% | -143.4% | -852.2% | -986.8% | |
| – | 12.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -364.8% | -2,180.2% | – | – | -648.3% | 0.0% | 0.0% | -271.1% | |
| – | 3.5% | – | – | – | 546.6% | -2,169.2% | – | – | 3,070.0% | -1.6% | 1,101.1% | 1,284.0% | |
| – | 32.4% | – | – | – | -50.1% | 3,691.3% | – | – | 970.2% | -525.4% | -279.6% | -115.8% | |
| – | -459.8% | – | – | – | -844.9% | -4,767.4% | – | – | 20.1% | -381.3% | -530.3% | -417.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.